Arcadia Biosciences, Inc. — Director's Dealing 2020

Feb 4, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2020-02-03

Reporting Person: Reiter Sarah (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-03	Common Stock	P	700	$1.72	Acquired	3800	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-03	Stock Option (right to buy)	$4.91	A	50000	Acquired	2030-02-03	Common Stock (50000)	Direct

Footnotes

F1: Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.

F2: The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024.